May 31, 2019 — RefleXion Medical recently announced the opening of its new manufacturing facility at its headquarters in Hayward, Calif. The 50,000 square-foot facility includes six state-of-the-art linear accelerator testing vaults for the RefleXion machine and will house manufacturing, quality control, and a customer education center with a radiation oncology suite for clinical training.
The new facility, which is the third building on the company’s campus, took 11 months to complete and required over 12 million pounds of concrete. In conjunction with the City of Hayward, RefleXion held an official ribbon-cutting ceremony on May 22.
RefleXion’s biology-guided radiotherapy (BgRT) platform is the first, according to the company, to utilize the cancer itself to guide radiation delivery, even in tumors that are moving. The patented technology uses positron emission tomography (PET), the gold standard in cancer staging, one day enabling multiple tumors to continuously signal their location during treatment. PET uses a tracer drug that is accumulated by the tumors and produces emissions illuminating their locations. The RefleXion machine detects the emissions and immediately sends beamlets of radiation directly to the tumor to destroy it.
For more information: www.reflexion.com
October 19, 2026 
